Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 c » 25 c (Expand Search)
Showing 721 - 740 results of 101,811 for search '(( 5 c decrease ) OR ( 5 ((((step decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 2.05s Refine Results
  1. 721
    FFA treatment for 48 hours induced decrease of IFNAR1 in Huh-7.5 cells is mediated by a lysosomal degradation pathway.

    FFA treatment for 48 hours induced decrease of IFNAR1 in Huh-7.5 cells is mediated by a lysosomal degradation pathway. by Ramazan Kurt (449801)

    Published 2015
    Save to List
    Saved in:
  2. 722
    The numbers of parasite cysts in the brain decrease and the sizes increase as <i>Toxoplasma gondii</i> infection progresses in mice C57BL/6.

    The numbers of parasite cysts in the brain decrease and the sizes increase as <i>Toxoplasma gondii</i> infection progresses in mice C57BL/6. by Leda Castaño Barrios (8524317)

    Published 2021
    Save to List
    Saved in:
  3. 723
    Islet apoptosis increases in HFD-PBS and HFD-MSCs-NR and decreases in HFD-MSCs-R.

    Islet apoptosis increases in HFD-PBS and HFD-MSCs-NR and decreases in HFD-MSCs-R. by Patricia de Godoy Bueno (731717)

    Published 2015
    Save to List
    Saved in:
  4. 724
    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells.

    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

    Published 2024
    Save to List
    Saved in:
  5. 725
    Fig 5 -

    Fig 5 - by Mary J. Obayemi (11813022)

    Published 2021
    Save to List
    Saved in:
  6. 726
    Decreased expression of V-ATPase upon the siRNA transfection.

    Decreased expression of V-ATPase upon the siRNA transfection. by Manisha Naskar (2613763)

    Published 2023
    Save to List
    Saved in:
  7. 727
    Decreased expression of ATG5 upon the siRNA transfection.

    Decreased expression of ATG5 upon the siRNA transfection. by Manisha Naskar (2613763)

    Published 2023
    Save to List
    Saved in:
  8. 728
    Reduced ADAMTS-12 expression levels decrease EVT invasion.

    Reduced ADAMTS-12 expression levels decrease EVT invasion. by Alexander G. Beristain (225001)

    Published 2011
    Save to List
    Saved in:
  9. 729
    Higher baseline PV rates decrease the need for interneuron specialization.

    Higher baseline PV rates decrease the need for interneuron specialization. by Joram Keijser (12475353)

    Published 2022
    Save to List
    Saved in:
  10. 730
    Early increase and later decrease in GSK-3β activity.

    Early increase and later decrease in GSK-3β activity. by Arie J. Hoogendijk (353624)

    Published 2013
    Save to List
    Saved in:
  11. 731
    Brain uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice.

    Brain uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) in 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 732
    Decrease of actin velocity when passing confined TCR clusters.

    Decrease of actin velocity when passing confined TCR clusters. by Cheng-han Yu (244912)

    Published 2010
    Save to List
    Saved in:
  13. 733
    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA.

    Cellular uptake of [<sup>14</sup>C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 734
    Fig 5 -

    Fig 5 - by Jacob C. Jentzer (4746999)

    Published 2022
    Save to List
    Saved in:
  15. 735
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 736
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 737
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 738
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 739
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 740
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: